Las mejores jugadas también se escriben  Ver más

Enviar a
Provincia de Madrid
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

portada Envisioning a Transformed Clinical Trials Enterprise for 2030. Proceedings of a Workshop

Envisioning a Transformed Clinical Trials Enterprise for 2030. Proceedings of a Workshop

Board On Health Sciences Policy;Theresa Wizemann;Carolyn Shore;Amanda Wagner Gee;Health And Medicine Division;Engineering, And Medicine National Academies Of Sciences;Development, And Translation Forum On Drug Discovery (Autor) · National Academies Press · Tapa Blanda

Envisioning a Transformed Clinical Trials Enterprise for 2030. Proceedings of a Workshop - Board on Health Sciences Policy;Theresa Wizemann;Carolyn Shore;Amanda Wagner Gee;Health and Medicine Division;Engineering, and Medicine National Academies of Sciences;Development, and Translation Forum on Drug Discovery

Libro Nuevo Origen: España
Envío: 8 a 10 días háb.
27,56 €26,18 €
-5%
Libro Nuevo

Quedan 50 unidades

26,18 €
Llega entre el 03 Jul y el 09 Jul a Provincia de Madrid. Seleccionar ubicación

Reseña del libro "Envisioning a Transformed Clinical Trials Enterprise for 2030. Proceedings of a Workshop"

The evolution of health care is expanding the possibilities for integration of clinical research into the continuum of clinical care; new approaches are enabling the collection of data in real-world settings; and new modalities, such as digital health technologies and artificial intelligence applications, are being leveraged to overcome challenges and advance clinical research. At the same time, the clinical research enterprise is strained by rising costs, varying global regulatory and economic landscapes, increasing complexity of clinical trials, barriers to recruitment and retention of research participants, and a clinical research workforce that is under tremendous demands. Looking ahead to 2030, the Forum on Drug Discovery, Development, and Translation of the National Academies of Sciences, Engineering, and Medicine convened a public workshop for stakeholders from across the drug research and development life cycle to reflect on the lessons learned over the past 10 years and consider opportunities for the future. The workshop was designed to consider goals and priority action items that could advance the vision of a 2030 clinical trials enterprise that is more efficient, effective, person-centered, inclusive, and integrated into the health care delivery system so that outcomes and experiences for all stakeholders are improved. This Proceedings of a Workshop summarizes the presentations and discussions that took place during the four-part virtual public workshop held on January 26, February 9, March 24, and May 11, 2021. Table of ContentsFront Matter1 Introduction2 Defining the Vision3 Enhancing Outcomes in a More Person-Centered and Inclusive Clinical Trials Enterprise4 Practical Applications for Technology to Enhance the Clinical Trials Enterprise5 Building a More Resilient, Sustainable, and Transparent Clinical Trials Enterprise6 Opportunities for TransformationReferencesAppendix A: Health Affairs Blog PostsAppendix B: Speaker and Moderator BiographiesAppendix C: Workshop Agendas

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes